In addition to biomarkers such as CRP which is known to be elevated in PAH and CTEPH and shown to be predictive of outcome and sensitive to therapies42 and NT-proBNP with high levels highly prognostic of right ventricular failure43, age of diagnosis, BMI and renal function were also identified. The gene discussed is CRP; the disease is chronic thromboembolic pulmonary hypertension.